+254.2%
MRNA vs LBRT
-28.0%
+282.2%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | LBRT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | +3.3% | -4.1% | -1.2% |
| 7D | -3.8% | -1.9% | -1.8% | -3.6% |
| 30D | +16.4% | -32.0% | +48.4% | +21.0% |
| 3M | +310.6% | -39.7% | +350.3% | +330.8% |
| 6M | +370.3% | -61.1% | +431.4% | +440.2% |
| YTD | +743.3% | -29.4% | +772.7% | +714.5% |
| 1Y | +841.7% | -24.5% | +866.1% | +790.4% |
| All | +254.2% | -28.0% | +282.2% | +226.8% |
Cumulative growth
Daily Returns
Daily percentage return beside LBRT.
Daily Out/Under-Performance
Portfolio return minus LBRT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LBRT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded LBRT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling